These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

676 related articles for article (PubMed ID: 31304982)

  • 1. Advancements in nanotherapeutics for Alzheimer's disease: current perspectives.
    Harilal S; Jose J; Parambi DGT; Kumar R; Mathew GE; Uddin MS; Kim H; Mathew B
    J Pharm Pharmacol; 2019 Sep; 71(9):1370-1383. PubMed ID: 31304982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanotechnology-based drug delivery systems for the treatment of Alzheimer's disease.
    Fonseca-Santos B; Gremião MP; Chorilli M
    Int J Nanomedicine; 2015; 10():4981-5003. PubMed ID: 26345528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic strategies and nano-drug delivery applications in management of ageing Alzheimer's disease.
    Karthivashan G; Ganesan P; Park SY; Kim JS; Choi DK
    Drug Deliv; 2018 Nov; 25(1):307-320. PubMed ID: 29350055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in nanomedicine for the treatment of Alzheimer's and Parkinson's diseases.
    Hernando S; Gartziandia O; Herran E; Pedraz JL; Igartua M; Hernandez RM
    Nanomedicine (Lond); 2016 May; 11(10):1267-85. PubMed ID: 27077453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanotechnology-based Drug Delivery for Alzheimer's and Parkinson's Diseases.
    Nguyen-Thi PT; Ho TT; Nguyen TT; Vo GV
    Curr Drug Deliv; 2024; 21(7):917-931. PubMed ID: 37424345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of nanomedicines in delivery of anti-acetylcholinesterase compounds to the brain in Alzheimer's disease.
    Ahmad MZ; Ahmad J; Amin S; Rahman M; Anwar M; Mallick N; Ahmad FJ; Rahman Z; Kamal MA; Akhter S
    CNS Neurol Disord Drug Targets; 2014; 13(8):1315-24. PubMed ID: 25345516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Research Progress of Nanocarriers for the Treatment of Alzheimer's Disease.
    Li L; Zhang J; Huang X; Du J; Tu Z; Wu H; Liu X; Yuan M
    Curr Pharm Des; 2023; 29(2):95-115. PubMed ID: 36529920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Innovative Therapies and Nanomedicine Applications for the Treatment of Alzheimer's Disease: A State-of-the-Art (2017-2020).
    Binda A; Murano C; Rivolta I
    Int J Nanomedicine; 2020; 15():6113-6135. PubMed ID: 32884267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanomedicine: A New Frontier in Alzheimer's Disease Drug Targeting.
    Pathak K; Ahmad MZ; Saikia R; Pathak MP; Sahariah JJ; Kalita P; Das A; Islam MA; Pramanik P; Tayeng D; Abdel-Wahab BA
    Cent Nerv Syst Agents Med Chem; 2024 Mar; ():. PubMed ID: 38551038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanotechnology and Alzheimer's disease: what has been done and what to do.
    Ruozi B; Belletti D; Pederzoli F; Veratti P; Forni F; Vandelli MA; Tosi G
    Curr Med Chem; 2014; 21(36):4169-85. PubMed ID: 25039777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanotechnological strategies for nerve growth factor delivery: Therapeutic implications in Alzheimer's disease.
    Faustino C; Rijo P; Reis CP
    Pharmacol Res; 2017 Jun; 120():68-87. PubMed ID: 28351757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent Advances in Targeted Drug Delivery Approaches Using Lipidic and Polymeric Nanocarriers for the Management of Alzheimer's Disease.
    Jain D; Rashid MA; Ahmad FJ
    Curr Pharm Des; 2021; 27(43):4388-4403. PubMed ID: 34579627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alzheimer's disease and its treatment by different approaches: A review.
    Srivastava S; Ahmad R; Khare SK
    Eur J Med Chem; 2021 Apr; 216():113320. PubMed ID: 33652356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanocarrier mediated drug delivery as an impeccable therapeutic approach against Alzheimer's disease.
    Taliyan R; Kakoty V; Sarathlal KC; Kharavtekar SS; Karennanavar CR; Choudhary YK; Singhvi G; Riadi Y; Dubey SK; Kesharwani P
    J Control Release; 2022 Mar; 343():528-550. PubMed ID: 35114208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multifunctional Nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimaging.
    Bhaskar S; Tian F; Stoeger T; Kreyling W; de la Fuente JM; Grazú V; Borm P; Estrada G; Ntziachristos V; Razansky D
    Part Fibre Toxicol; 2010 Mar; 7():3. PubMed ID: 20199661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Revolutionizing neurotherapeutics: Nanocarriers unveiling the potential of phytochemicals in Alzheimer's disease.
    Kamath AP; Nayak PG; John J; Mutalik S; Balaraman AK; Krishnadas N
    Neuropharmacology; 2024 Nov; 259():110096. PubMed ID: 39084596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multifunctional Nanocarriers for Alzheimer's Disease: Befriending the Barriers.
    Ansari MA; Tripathi T; Venkidasamy B; Monziani A; Rajakumar G; Alomary MN; Alyahya SA; Onimus O; D'souza N; Barkat MA; Al-Suhaimi EA; Samynathan R; Thiruvengadam M
    Mol Neurobiol; 2024 May; 61(5):3042-3089. PubMed ID: 37966683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurotherapeutic applications of nanoparticles in Alzheimer's disease.
    Sahni JK; Doggui S; Ali J; Baboota S; Dao L; Ramassamy C
    J Control Release; 2011 Jun; 152(2):208-31. PubMed ID: 21134407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Designing and Formulation of Nanocarriers for "Alzheimer's and Parkinson's" Early Detection and Therapy.
    Abujamai J; Satar R; Ansari SA
    CNS Neurol Disord Drug Targets; 2024; 23(10):1251-1262. PubMed ID: 38351689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanotechnological applications for the treatment of neurodegenerative disorders.
    Modi G; Pillay V; Choonara YE; Ndesendo VM; du Toit LC; Naidoo D
    Prog Neurobiol; 2009 Aug; 88(4):272-85. PubMed ID: 19486920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.